Rousselot low endotoxin gelatins and collagens for biomedical applications

By Rousselot Biomedical

This whitepaper outlines the benefits of gelatin and collagen for (bio)medical applications and highlights the importance of low endotoxin levels for optimal API (Active Pharmaceutical Ingredients) delivery and (bio)medical engineering materials. The paper also highlights the value-added expertise that Rousselot can offer to researchers, developpers and manufacturers of (bio)medical applications of gelatin, hydrolyzed gelatin and collagen.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.